Related Experiment Videos
Disclosure and rationality: comparative risk information and decision-making about prevention
1Indiana University Center for Bioethics, Indiana University School of Medicine, Indiana University-Purdue University, Indianapolis (IUPUI), 410 W. 10th St., Suite 3100, Indianapolis, IN 46202, USA. phschwar@iupui.edu
Theoretical Medicine and Bioethics
|June 25, 2009
Summary
Comparative risk information, detailing if a patient's disease risk is above or below average, can aid medical decision-making. This information, when presented alongside personal risk and treatment effects, supports rational health choices.
Area of Science:
- Medical decision-making
- Health risk communication
- Preventive medicine
Background:
- Growing emphasis on preventive medicine necessitates effective risk communication strategies.
- Concerns exist that comparative risk information may distract patients from personal risk data and treatment specifics.
- Theories of rationality underpin debates on optimal patient information disclosure.
Purpose of the Study:
- To evaluate the role of comparative risk information in patient decision-making.
- To challenge the view that comparative risk data hinders rational medical choices.
- To explore the theoretical underpinnings of risk communication in medicine.
Main Methods:
- Analysis of existing arguments against comparative risk information.
- Exploration of theories of rationality in medical decision-making.
- Philosophical inquiry into the goals of prevention and rational choice.
Main Results:
- Comparative risk information can positively influence patient decision-making.
- Criticisms of comparative risk disclosure are based on a narrow view of prevention.
- Rational choice in medicine can incorporate comparative risk data effectively.
Conclusions:
- Comparative risk information is a valuable tool in preventive medicine.
- A broader understanding of rationality supports the use of comparative risk data.
- Effective risk communication enhances informed patient decision-making.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
01:21Types of Reports II: Incident or Occurrence Report
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
01:26Levels of Health Promotion and Illness Prevention
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
01:25Strategies for Assessing and Addressing Confounding
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...